Daxiang Biotech
Haidian
About Daxiang Biotech
Daxiang Biotech develops and produces human organoid chips. It is committed to promoting organoid chips in new drug research and development, disease modeling, and individualization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $27.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2026)
- Website: daxiangbio.com
- Phone: 010-62370096
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/daxiang-biotech-43014 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.